ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Diagnostic criteria"

  • Abstract Number: 1893 • ACR Convergence 2020

    Predictors of Response in Secukinumab-treated Patients with Ankylosing Spondylitis: Logistic Regression and Machine Learning Analyses

    Corinne Miceli-Richard1, Denis Poddubnyy2, Atul Deodhar3, Weibin Bao4, Craig Parman5, Brian Porter6 and Effie Pournara5, 1Paris Descartes University, Department of Rheumatology - Hôpital Cochin, Assistance Publique - Hôpitaux de Paris, Paris, France, 2Charité – Universitätsmedizin Berlin, Berlin, Germany, 3Oregon Health & Science University, Portland, OR, 4Novartis Pharmaceuticals Corporation, East Hannover, 5Novartis Pharma AG, Basel, Switzerland, 6Novartis Pharmaceuticals Corporation, East Hanover, NJ

    Background/Purpose: Predicting outcomes early in the disease course in patients (pts) with ankylosing spondylitis (AS) is challenging, owing to heterogeneity of symptoms, varying disease severity,…
  • Abstract Number: 1939 • ACR Convergence 2020

    Definitions and Reliability Assessment of Chronic Ultrasound Lesions of the Axillary Artery in Giant Cell Arteritis: A Study from the OMERACT Large Vessel Vasculitis Ultrasound Working Group

    Valentin Schaefer1, Stavros Chrysidis2, Greta Carrara3, Wolfgang Schmidt4, George A. Bruyn5, Bhaskar Dasgupta6, Eugenio De Miguel7, Andreas Diamantopoulos8, Christina Duftner9, Ulrich Fredberg10, Berit Nielsen11, Wolfgang Hartung12, Alojzija Hocevar13, Annamaria Iagnocco14, Aaron Juche4, Tanaz Kermani15, Tove Lorenzen16, Pierluigi Macchioni17, Marcin Milchert18, Uffe Døhn19, Sara Monti20, Chetan Mukhtyar21, Cristina Ponte22, Carlo Scire23, Lene Terslev24, Luca Seitz25 and Christian Dejaco26, 1Clinic of Internal Medicine III, Department of Oncology, Hematology and Rheumatology, University Hospital Bonn, Germany, Bonn, Nordrhein-Westfalen, Germany, 2Sydvestjysk Sygehus Esbjerg, Esbjerg, Denmark, 3Epidemiology Unit, Italian Society for Rheumatology, Milan, Italy, 4Immanuel Krankenhaus Berlin Buch, Berlin, Germany, 5Rheumatology, Reumakliniek Lelystad, Lelystad, Netherlands, 6Rheumatology, Mid and South Essex University Hospital NHS Foundation Trust, Southend University Hospital, United Kingdom, Westcliff on sea, England, United Kingdom, 7Rheumatology Department, Hospital Universitario La Paz, Madrid, Spain, 8Martina Hansens Hospital, Baerum, Norway, 9Medical University Innsbruck, Innsbruck, Austria, 10Silkeborg Regional Hospital, Silkeborg, Denmark, 11Aarhus University Hospital, Aarhus, Denmark, 12Asklepios Klinik Bad Abbach, Bad Abbacg, Germany, 13University Medical Center, Rheumatology, Ljubljana, LJUBLJANA, Slovenia, 14Università degli Studi di Torino, Academic Rheumatology Centre, Turin, Italy, 15David Geffen School of Medicine / University of California, Los Angeles, CA, 16Copenhagen Center for Arthritis Research, Copenhagen, Denmark, 17Unità Operativa di Reumatologia/Arcispedale S. Maria Nuova, Reggio Emilia, Italy, 18Pomeranian Medical University, Szczecin, Poland, 19Center for Rheumatology and Spine Diseasesand COPECARE, Copenhagen, Denmark, 20Fondazione IRCCS Policlinico S Matteo, University of Pavia, Pavia, Italy, 21Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, United Kingdom, 22Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisboa, Portugal, 23University of Ferrara, Ferrara, Italy, 24Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup., Copenhagen, Denmark, 25Department of Rheumatology, Immunology and Allergology, University of Bern, Inselspital, Switzerland, Bern, Switzerland, 26South Tyrol Health Trust, Hospital of Bruneck, Bruneck, Italy

    Background/Purpose: The OMERACT Ultrasound (US) large vessel vasculitis task force has recently defined the US appearance of normal axillary arteries (AA) and the key elementary…
  • Abstract Number: 0026 • ACR Convergence 2020

    A Modified Version of the 2016 ACR Fibromyalgia Criteria Cognitive Items Results in Stronger Correlation Between Subjective and Objective Measures of Cognitive Impairment

    Valerie Aloush1, Chen Yaalon2, Sheer Raev2, Noy Sobol2, Jacob Ablin1, Ran Shorer3 and Odelia Elkana2, 1Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 2Academic College Tel Aviv Jaffa, Tel Aviv, Israel, 3Tel Aviv Medical Center, Tel Aviv, Israel

    Background/Purpose: In a previous study, we showed that the subjective item assessing cognitive impairment (SSS-Cog) for fibromyalgia (FM) did not correlate with objective cognitive measures.…
  • Abstract Number: 2019 • ACR Convergence 2020

    Preliminary Definition of a Positive MRI for Active Lesions in the Sacroiliac Joints Typical of Axial Spondyloarthritis

    Walter Maksymowych1, Xenofon Baraliakos2, Ulrich Weber3, Pedro M Machado4, Susanne J Pedersen5, Joachim Sieper6, Stephanie Wichuk1, Denis Poddubnyy7, Martin Rudwaleit8, Désirée van der Heijde9, Robert Landewé10, Joel Paschke11, Mikkel Østergaard12 and Robert G Lambert13, 1University of Alberta, Edmonton, AB, Canada, 2Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Bochum, Germany, 3University of South Denmark, Odense, Denmark, 4University College London, London, United Kingdom, 5Rigshospitalet University, Copenhagen, Denmark, 6Charité Universitätsmedizin Berlin, Berlin, Germany, 7Charité – Universitätsmedizin Berlin, Berlin, Germany, 8Department of Internal Medicine and Rheumatology, Klinikum Bielefeld, Germany, 9Leiden University Medical Center, Leiden, Netherlands, 10Amsterdam University Medical Center & Zuyderland Hospital, Amsterdam, Netherlands, 11CARE Arthritis, Edmonton, AB, Canada, 12Rigshospitalet, University of Copenhagen, Copenhagen, Denmark, 13University of Alberta and CARE Arthritis, Edmonton, AB, Canada

    Background/Purpose: The ASAS definition of a positive MRI for inflammation (ASAS-MRI+) is intended for classification of patients as having axSpA but is often misused for…
  • Abstract Number: 0094 • ACR Convergence 2020

    Validation Study of Proposed Diagnostic Criteria for Sympathetic Joint Effusion

    Justin Levinson1, Mali Jurkowski2, Jasleen Kahlon3, Hayoung Youn4, Daohai Yu3 and Irene Tan5, 1Section of Rheumatology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, 2Temple University, Philadelphia, PA, 3Temple University, Philadelphia, 4Temple University Medical School, Philadelphia, 5Albert Einstein Healthcare Network, Philadelphia, PA

    Background/Purpose: Sympathetic joint effusion (SJE) is a rarely diagnosed rheumatologic entity characterized by painful yet non-inflammatory range synovial effusion. The condition was originally described in…
  • Abstract Number: 0159 • ACR Convergence 2020

    Patient-Reported Data Show the Impact of Time to Diagnosis in RA

    Kelly O'Neill1, Kathryne Marks2, John Davis3 and Cynthia Crowson4, 1Rheumatoid Patient Foundation, Orlando, FL, 2Rosalind Franklin University of Medicine and Science, North Chicago, IL, 3Mayo Clinic, Rochester, MN, 4Mayo Clinic, Rochester, Minnesota, USA, Rochester, MN

    Background/Purpose: Time from diagnosis to treatment has been well established to correlate with better outcomes in rheumatoid arthritis (RA). Treatment delays are often associated with…
  • Abstract Number: 0445 • ACR Convergence 2020

    Dual-Energy CT in Gout Patients: Do All Color-Coded Lesions Actually Represent Monosodium Urate Crystals?

    Sara Christiansen1, Felix Müller2, Mikkel Østergaard3, Ole Slot1, Jakob Møller2, Henrik Børgesen2, Kasper Gosvig2 and Lene Terslev4, 1Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup., Glostrup, Denmark, 2Department of Radiology, Herlev and Gentofte Hospital, Herlev, Denmark, 3Rigshospitalet, University of Copenhagen, Copenhagen, Denmark, 4Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup., Copenhagen, Denmark

    Background/Purpose: Dual-Energy CT (DECT) can acknowledge differences in tissue compositions and can color-code tissues with specific features including monosodium urate (MSU) crystals. However, when evaluating…
  • Abstract Number: 0519 • ACR Convergence 2020

    Thrombotic and Obstetric Associations of Non-Criteria Antiphospholipid Immunoassays That Detect Antibodies to Neutral and Negatively-Charged Phospholipid

    Rohan Willis1, E Nigel Harris2, Vijaya Murthy3, Zurina Romay-Penabad1, Alvaro Schleh4, Monica Smikle2, Karel De Ceulaer2, Anne Tebo5, Troy Jaskowski6, Marta Guerra7, David Ware Branch8, Jane Salmon7, Michelle Petri9 and Emilio Gonzalez1, 1University of Texas Medical Branch, Galveston, TX, 2University of the West Indies, Kingston, Jamaica, 3University of Texas Medical Branch, League City, TX, 4Antiphospholipid Standardization Laboratory, GALVESTON, TX, 5Department of Pathology, University of Utah, Salt Lake City, 6ARUP Laboratories, Salt Lake City, UT, 7Hospital for Special Surgery, New York, NY, 8University of Utah, Salt Lake City, 9Johns Hopkins University School of Medicine, Baltimore

    Background/Purpose: Criteria antiphospholipid (aPL) antibodies that identify antiphospholipid syndrome (APS) patients, anticardiolipin (aCL) and anti-β2glycoprotein-I (anti-β2GPI), have demonstrated inconsistent specificity and sensitivity in this regard…
  • Abstract Number: 135 • 2019 ACR/ARP Annual Meeting

    Added Clinical Utility of Testing for Extra-Criteria Antibodies Specificities Beyond Sapporo and Sydney Criteria Recommendations

    Savino Sciascia1, Irene Cecchi 2, Massimo Radin 2, Elena Rubini 2, Silvia Grazietta Foddai 2, Dario Roccatello 2, Chelsea Bentow 3, Andrea Seaman 3, Carlos Ramirez 3 and Michael Mahler 3, 1Center of Research of Immunopathology and Rare Diseases- Coordinating Center of Piemonte and Valle d’Aosta Network for Rare Diseases, Department of Clinical and Biological Sciences, University of Turin, Torino, Italy, 2University of Turin, Turin, Italy, 3Inova Diagnostics, San Diego, CA

    Background/Purpose: The laboratory diagnostics of antiphospholipid syndrome (APS) takes into account the persistent positivity for anticardiolipin (aCL) and/or anti-β2glycoprotein I (anti-β2GPI) antibodies and/or the presence…
  • Abstract Number: 1443 • 2018 ACR/ARHP Annual Meeting

    Ultrasonographic Criteria for the Diagnosis of Erosive Rheumatoid Arthritis Disease Using Osteoarthritic Patients As Controls Compared to Validated Radiographic Criteria

    Camille Roux1, Frédérique Gandjbakhch2, Audrey Pierreisnard3, Marion Couderc4, Cédric Lukas5, Racha Masri1, Jean-Philippe Sommier1, Isabelle Clerc-Urmès6, Cedric Baumann7, Isabelle Chary-Valckenaere8 and Damien Loeuille9, 1Rheumatology, CHRU Nancy, Vandoeuvre les Nancy, France, 2UPMC University Paris 06, Pitié-Salpétrière Hospital, Paris, France, 3APHP, Paris, France, 4Rheumatology, CHU Gabriel Montpied, Clermont-Ferrand, France, 5Rheumatology, Lapeyronie Hospital and EA2415 Montpellier University, Montpellier, France, 6CHRU Nancy, Nancy, France, 7CHRU Nancy, Vandoeuvre les Nancy, France, 8Rheumatology, CHRU Nancy, Vandoeuvres les Nancy, France, 9Rheumatology, University Hospital of Nancy, NANCY, France

    Background/Purpose: Rheumatoid arthritis (RA) is the most prevalent chronic inflammatory joint disease (1,2) responsible for structural damage. Radiography (RX) is considered as the gold standard…
  • Abstract Number: 1813 • 2018 ACR/ARHP Annual Meeting

    Non-Aphthous Beginning As an Independent Risk Factor for the Course of Behçet’s Disease

    Muhammed Aydin1, Bahar Artim-Esen1, Murat Inanc2, Lale Ocal1 and Ahmet Gül1, 1Department of Internal Medicine, Division of Rheumatology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, 2Department of Internal Medicine, Division of Rheumatology, Istanbul University, Istanbul Faculty of Medicine, İstanbul, Turkey

    Background/Purpose: Behçet disease (BD) is a multisystem inflammatory disorder characterized by recurrent manifestations in mucocutaneous tissues, eyes, joints, blood vessels, intestines and brain. Since there…
  • Abstract Number: 1836 • 2018 ACR/ARHP Annual Meeting

    Fibromyalgia Diagnosis and Biased Assessment: Sex, Prevalence, Biology and Bias

    Brian Walitt1, Frederick Wolfe2, serge Perrot3, Johannes Rasker4 and Winfried Häuser5, 1National Institutes of Health, National Institute of Nursing Research, Bethesda, MD, 2FORWARD, The National Databank for Rheumatic Diseases, Wichita, KS, 3Pain Clinic, Cochin-Hôtel Dieu Hospital, Paris, France, 45Faculty of Behavioral Management & Social sciences, Psychology, Health & Technology, University of Twente, Enschede, the Netherlands, Enschede, Netherlands, 5Department of Psychosomatic Medicine and Psychotherapy, Technische Universität München, Munich, Germany

    Background/Purpose: Multiple clinical and epidemiological studies have provided estimates of fibromyalgia prevalence and sex ratio, but different criteria sets and methodology, as well as bias,…
  • Abstract Number: 877 • 2017 ACR/ARHP Annual Meeting

    Modification of the  Classification Criteria for Primary Sjögren Syndrome: An International Vignette Survey

    Sandrine Jousse-Joulin1, Florence Gatineau2, Chiara Baldini3, Alan N. Baer4, Francesca Barone5, Hendrika Bootsma6, Simon Bowman7, Pilar Brito Zeron8, Divi Cornec9, Thomas Doerner10, Salvatore De Vita11, Benjamin Fisher12, Daniel S. Hammenfors13, Malin V. Jonsson14, Xavier Mariette15, Vera Milic16, Hideki Nakamura17, Wan-Fai Ng18, Emmanuel Nowak2, Manuel Ralos-Casals19, Astrid Rasmussen20, Raphaèle Seror21, Caroline Shiboski22, Takashi Nakamura23, Arjan Vissink24, Alain Saraux25 and Valérie Devauchelle-Pensec1, 1Rheumatology, Brest university medical school, EA 2216, UBO and CHU de la Cavale Blanche,, Brest, France, 2INSERM CIC 1412, Brest Medical University Hospital, Brest, France, 3Internal Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy, 4Medicine (Rheumatology), Johns Hopkins University School of Medicine, Baltimore, MD, 5Institute of Inflammation and Ageing (IIA), University of Birmingham, Birmingham, United Kingdom, 6Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands, 7Department of Rheumatology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK, Birmingham, United Kingdom, 8Autoimmune Diseases Unit, Department of Internal Medicine, Hospital CIMA-Sanitas, Barcelona, Spain, 9CHU Brest, Brest, France, 10Charité Universitätmedizin Berlin and DRFZ, Berlin, Germany, 11Rheumatology Clinic, Academic Hospital S. M. della Misericordia, Medical Area Department, University of Udine, Italy, Udine, Italy, 12Rheumatology Research Group, University of Birmingham, Birmingham, United Kingdom, 13Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway, Bergen, Norway, 14Section for Oral and Maxillofacial Radiology, Department of Clinical Dentistry, University of Bergen, Bergen, Norway, Bergen, Norway, 15Université Paris Sud, Paris, France, 16Institute of Rheumatology, School of Medicine, University of Belgrade, Belgrade, Serbia, 17Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 18Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom, 19Department of Medicine, University of Barcelona, Barcelone, Spain, 20Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 21Assistance Publique-Hôpitaux de Paris (APHP), Hôpitaux universitaires Paris Sud, Université Paris Sud, kremlin bicetre, France, 22Department of Orofacial Sciences, School of Dentistry, University of California, San Francisco, CA, 23Department of Radiology and Cancer Biology, Nagasaki University School of Dentistry, Nagasaki, Japan, 24Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 25Rheumatology Department, Rheumatology Department, CHU de la Cavale Blanche, Brest, France, Brest Cedex, France

    Background/Purpose: The common classification criteria sets of primary Sjogren syndrome, did not considered the ultrasonography (US) of the major salivary glands as a useful item.…
  • Abstract Number: 2048 • 2017 ACR/ARHP Annual Meeting

    the Impact of Diagnostic Misregistration of Rheumatoid Arthritis on the Establishment of a Value Based Healthcare System

    Nienke Conijn1,2, Deirisa Lopes Barreto1, Martijn Kuijper1, Matthijs van der Steen3, Jaco van der Kooij4, Angelique Weel2,5, J.M.W. Hazes2 and Marc R Kok1, 1Rheumatology, Maasstad Hospital, Rotterdam, Netherlands, 2Rheumatology, Erasmus University Medical Center, Rotterdam, Netherlands, 3Business Intelligence, Maasstad Hospital, Rotterdam, Netherlands, 4Planning and Control, Maasstad Hospital, Rotterdam, Netherlands, 5Department of Rheumatology, Maasstad Hospital, Rotterdam, Netherlands

    Background/Purpose: Value based health care has gained worldwide attention due to the refocusing vision of creating value around and for patients. The latter is obtained…
  • Abstract Number: 2556 • 2017 ACR/ARHP Annual Meeting

    Were Moll and Wright Right?

    Sergio Schwartzman1, Madeline Epsten2, Jackie Szymonifka2, Stephen A. Paget3 and Lisa A. Mandl1, 1Rheumatology, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, 2Rheumatology, Hospital for Special Surgery, New York, NY, 3Division of Rheumatology, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY

    Background/Purpose: In 1973 Moll and Wright published the first paper on the classification criteria for Psoriatic Arthritis (PsA). In their pioneering work, these authors additionally…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology